Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans

Blood

Volumn 82, Issue 10, 1993, Pages 2985-2990

  Granowitz, E V ^a   Porat, R ^a   Mier, J W ^a   Orencole, S F ^a   Callahan, M V ^a   Cannon, J G ^a   Lynch, E A ^a   Ye, K ^a   Poutsiaka, D D ^a   Vannier, E ^a   Shapiro, L ^a   Pribble, J P ^a   Stiles, D M ^a   Catalano, M A ^a   Wolff, S M ^a   Dinarello, C A ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CYTOKINE; ESCHERICHIA COLI ENDOTOXIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN EXPERIMENT; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; MITOGENESIS; MONONUCLEAR CELL; NEUTROPHILIA; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYMPTOMATOLOGY;

EID: 0027489870     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v82.10.2985.2985     Document Type: Article

References (0)